These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

937 related items for PubMed ID: 9361954

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ, Connors M, Flanigan ME, Geiger SP, Ford H, Baseler M, Adelsberger J, Davey RT, Lane HC.
    J Immunol; 1995 Jun 15; 154(12):6612-23. PubMed ID: 7759895
    [Abstract] [Full Text] [Related]

  • 3. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
    Shiroki R, Poindexter NJ, Woodle ES, Hussain MS, Mohanakumar T, Scharp DW.
    Transplantation; 1994 Jun 15; 57(11):1555-62. PubMed ID: 8009588
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H, Ueda T, Kawahata M, Kobayashi K, Ebihara Y, Manabe A, Tanaka R, Ito M, Asano S, Nakahata T, Tsuji K.
    Bone Marrow Transplant; 2000 Dec 15; 26(11):1211-6. PubMed ID: 11149733
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts.
    Alegre ML, Peterson LJ, Jeyarajah DR, Weiser M, Bluestone JA, Thistlethwaite JR.
    J Immunol; 1994 Sep 15; 153(6):2738-49. PubMed ID: 8077678
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
    Williams SS, Umemoto T, Kida H, Repasky EA, Bankert RB.
    J Immunol; 1992 Oct 15; 149(8):2830-6. PubMed ID: 1401915
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
    Nonoyama S, Smith FO, Ochs HD.
    J Immunol; 1993 Oct 01; 151(7):3894-901. PubMed ID: 8376809
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Establishment of an xenogeneic acute graft-versus-host disease model in NOD/SCID mice by engraftment of G-CSF mobilized human mononuclear cells].
    Gao L, Wang JM, Xie LN, Zhou H, Qiu HY.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb 01; 29(2):87-91. PubMed ID: 18681307
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR, Taylor PA, Vallera DA.
    J Immunol; 1994 Apr 01; 152(7):3665-74. PubMed ID: 8144942
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. SCID mouse as a model for transplantation studies.
    Renz JF, Lin Z, de Roos M, Dalal AA, Ascher NL.
    J Surg Res; 1996 Sep 01; 65(1):34-41. PubMed ID: 8895604
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.